Cleared Traditional

K051030 - COAG-A-MATE MTX III

K051030 is an FDA 510(k) clearance for COAG-A-MATE MTX III, manufactured by bioMerieux, Inc.. The device is a Class 2 Hematology device with product code JPA cleared through the Traditional 510(k) pathway after a 245-day FDA review.

K051030 · bioMerieux, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2005
Decision
245d
Days
Class 2
Risk

K051030 is an FDA 510(k) clearance for the COAG-A-MATE MTX III. Classified as System, Multipurpose For In Vitro Coagulation Studies (product code JPA), Class II - Special Controls.

Submitted by bioMerieux, Inc. (Durham, US). The FDA issued a Cleared decision on December 23, 2005 after a review of 245 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all bioMerieux, Inc. devices

FDA 510(k) Submission Details - K051030

510(k) Number K051030 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 2005
Decision Date December 23, 2005
Days to Decision 245 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
132d slower than avg
Panel avg: 113d · This submission: 245d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JPA Device Classification - Class 2, Special Controls

Product Code JPA System, Multipurpose For In Vitro Coagulation Studies
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPA System, Multipurpose For In Vitro Coagulation Studies

All 158
Devices cleared under the same product code (JPA) and FDA review panel - the closest regulatory comparables to K051030.
STA-R EVOLUTION AUTOMATED MULTI-PARAMETRIC ANALYZER
K082675 · Diagnostica Stago, Inc. · Oct 2008
ACTALYKE QC KIT, MODELS AQC-HP AND AQC-LP
K061014 · Helena Laboratories · May 2006
ACL ELITE
K060162 · Instrumentation Laboratory CO · Feb 2006
HEMORAM/AGGRAM ANALYZER
K050053 · Helena Laboratories · Jul 2005
IMMEDIA PROTHROMBIN TIME SYSTEM
K050243 · Farallon Medial, Inc. · Jun 2005
MDA B.30
K050513 · bioMerieux, Inc. · Apr 2005